Pathogenic mechanisms in systemic lupus erythematosus

References

• Perl A. Pathogenesis and spectrum of autoimmunity. In: Perl A. editor. Autoimmunity, methods and protocols. Totowa, NJ: Humana Press; 2004. 1–8.
   Google Scholar
• Kyttaris VC, Juang YT, Tsokos GC. Immune cells and cytokines in systemic lupus erythematosus: An update. Curr Opin Rheumatol. 2005; 17:518–522 [see comment]. [Review] [29 refs].
   PubMed Web of Science ®Google Scholar
• Fox RI. Sjogren's syndrome: Immunobiology of exocrine gland dysfunction. Adv Dent Res. 1996; 10:35–40 [Review] [60 refs].
   PubMedGoogle Scholar
• Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM. Systemic lupus erythematosus. Ann Intern Med. 1991; 115:548–559.
   PubMed Web of Science ®Google Scholar
• Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, . Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008; 40 2: 204–210.
   PubMed Web of Science ®Google Scholar
• Kyttaris VC, Krishnan S, Tsokos GC. Systems biology in systemic lupus erythematosus: Integrating genes, biology and immune function. Autoimmunity. 2006; 39 8: 705–709.
   PubMed Web of Science ®Google Scholar
• Perl A, Banki K. Human endogenous retroviral elements and autoimmunity: Data and concepts. Trends Microbiol. 1993; 1:153–156.
   PubMedGoogle Scholar
• Perl A. Editorial. Endogenous retroviruses in pathogenesis of autoimmunity. J Rheumatol. 2001; 28:461–464.
   PubMed Web of Science ®Google Scholar
• Perl A. Role of endogenous retroviruses in autoimmune diseases. Rheum Dis Clin North Am. 2003; 29 1: 123–143 [Review] [177 refs].
   PubMed Web of Science ®Google Scholar
• Perl A, Nagy G, Koncz A, Gergely P, Fernandez D, Doherty E, . Molecular mimicry and immunomodulation by the HRES-1 endogenous retrovirus in SLE. Autoimmunity. 2008; 41 4: 287–297.
   PubMed Web of Science ®Google Scholar
• Magistrelli C, Banki K, Ferrante P, Perl A. Mapping and cloning of polymorphic genotypes of the HRES-1 LTR. Arth Rheum. 1994; 37:S316.
   PubMedGoogle Scholar
• Magistrelli C, Samoilova E, Agarwal RK, Banki K, Ferrante P, Vladutiu A, . Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics. 1999; 49:829–834.
   PubMed Web of Science ®Google Scholar
• Pullmann RJr, Bonilla E, Phillips PE, Middleton FA, Perl A. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arth Rheum. 2008; 58:532–540.
   PubMedGoogle Scholar
• Nagy G, Ward J, Mosser DD, Koncz A, Gergely P, Stancato C, . Regulation of CD4 expression via recycling by HRES-1/RAB4 controls susceptibility to HIV infection. J Biol Chem. 2006; 281:34574–34591.
   PubMed Web of Science ®Google Scholar
• Fernandez DR, Telarico T, Bonilla E, Li Q, Banerjee S, Middleton FA, . Activation of mTOR controls the loss of TCR. in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J Immunol. 2009; 182:2063–2073.
   PubMed Web of Science ®Google Scholar
• Kyttaris VC, Tsokos GC. T lymphocytes in systemic lupus erythematosus: An update. Curr Opin Rheumatol. 2004; 16:548–552 [Review] [36 refs].
   PubMed Web of Science ®Google Scholar
• Tsao BP, Cantor RM, Kalunian KC, Chen C-J, Badsha H, Singh R, . Evidence for linkage of a candidate chromosome 1 region to human systemic lupus erythematosus. J Clin Invest. 1997; 99:725–731.
   PubMed Web of Science ®Google Scholar
• Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malmgren ML, . A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA. 1998; 95:14875–14879.
   PubMed Web of Science ®Google Scholar
• Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, . Genome scan of human systemic lupus erythematosus: Evidence for linkage on chromosome 1q in African-American pedigrees. Proc Natl Acad Sci USA. 1998; 95:14869–14874.
   PubMed Web of Science ®Google Scholar
• Tsao BP, Cantor RM, Grossman JM, Shen N, Teophilov NT, Wallace DJ, . PARP alleles with the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest. 1999; 103:1135–1140.
   PubMed Web of Science ®Google Scholar
• Shai R, Quismorio FPJr, Li L, Kwon OJ, Morrison J, Wallace DJ, . Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet. 1999; 8 4: 639–644.
   PubMed Web of Science ®Google Scholar
• Yoshinobu K, Baudino L, Santiago-Raber ML, Morito N, Dunand-Sauthier I, Morley BJ, . Selective up-regulation of intact, but not defective env RNAs of endogenous modified polytropic retrovirus by the Sgp3 locus of lupus-prone mice. J Immunol. 2009; 182 12: 8094–8103.
   PubMed Web of Science ®Google Scholar
• Remmers EF, Plenge RM, Lee AT, Graham RR, Hom G, Behrens TW, . STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med. 2007; 357 10: 977–986.
   PubMed Web of Science ®Google Scholar
• Sigurdsson S, Nordmark G, G÷ring HHH, Lindroos K, Wiman AC, Sturfelt G, . Polymorphisms in the tyrosine kinase 2 and interferon regulatory Factor 5 Genes are associated with systemic lupus erythematosus. Am J Hum Genet. 2005; 76 3: 528–537.
   PubMed Web of Science ®Google Scholar
• Harley JB, Moser KL, Gaffney PM, Behrens TW. The genetics of human systemic lupus erythematosus. Curr Op Immunol. 1998; 10:690–696 [Review] [63 refs].
   PubMed Web of Science ®Google Scholar
• Jacob CO, Zhu J, Armstrong DL, Yan M, Han J, Zhou XJ, . Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci USA. 2009; 106 15: 6256–6261.
   PubMed Web of Science ®Google Scholar
• Lee-Kirsch MA, Gong M, Chowdhury D, Senenko L, Engel K, Lee YA, . Mutations in the gene encoding the 3[prime]-5[prime] DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet. 2007; 39 9: 1065–1067.
   PubMed Web of Science ®Google Scholar
• Stetson DB, Ko JS, Heidmann T, Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell. 2008; 134 4: 587–598.
   PubMed Web of Science ®Google Scholar
• Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, . Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005; 76 4: 561–571.
   PubMed Web of Science ®Google Scholar
• Rieck M, Arechiga A, Onengut-Gumuscu S, Greenbaum C, Concannon P, Buckner JH. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol. 2007; 179 7: 4704–4710.
   PubMed Web of Science ®Google Scholar
• Abelson AK, Delgado-Vega AM, Kozyrev SV, Sanchez E, Velazquez-Cruz R, Eriksson N, . STAT4 Associates with SLE through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk. Ann Rheum Dis. 2009; 68:1746–1753.
   PubMed Web of Science ®Google Scholar
• Vyshkina T, Sylvester A, Sadiq S, Bonilla E, Canter JA, Perl A, . Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus. Clin Immunol. 2008; 129:31–35.
   PubMed Web of Science ®Google Scholar
• Crow MK. Long interspersed nuclear elements (LINE-1): Potential triggers of systemic autoimmune disease. Autoimmunity. 2009; 43 1: 7–16.
   Web of Science ®Google Scholar
• Gorelik G, Richardson B. Key role of ERK pathway signaling in lupus. Autoimmunity. 2009a.
   Web of Science ®Google Scholar
• Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J Clin Invest. 2003; 111 4: 539–552.
   PubMed Web of Science ®Google Scholar
• Zan H, Zhang J, Ardeshna S, Xu Z, Park SR, Casali P. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: Concurrent up-regulation of somatic hypermutation and class switch DNA recombination. Autoimmunity. 200989–103.
   PubMed Web of Science ®Google Scholar
• Nambiar MP, Fisher CU, Warke VG, Krishnan S, Mitchell JP, Delaney N, . Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arth Rheum. 2003; 48:1948–1955.
   PubMedGoogle Scholar
• Perl A, Gonzalez-Cabello R, Lang I, Gergely P. Depressed natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells in patients with systemic lupus erythematosus. Immunol Commun. 1982; 11:431–440.
   PubMed Web of Science ®Google Scholar
• Perl A, Gonzalez-Cabello R, Gergely P. Depressed effector activity of OKT4+ and OKT8+T cell subsets in lectin-dependent cell-mediated cytotoxicity to HEP-2 cells in patients with systemic lupus erythematosus. J Clin Lab Immunol. 1984; 15:95–100.
   PubMedGoogle Scholar
• Via CS, Shearer GM. Defective in vitro IL-2 production in lupus is an early but secondary event paralleling disease activity: Evidence from the murine parent-into-F1 model supports staging of IL-2 defects in human lupus. Autoimmunity. 2009.
   Web of Science ®Google Scholar
• Perl A. Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance and selecting targets for treatment. Autoimmunity. 2009; 43 1: 32–47.
   Web of Science ®Google Scholar
• Desai BN, Myers BR, Schreiber SL. FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci USA. 2002; 99:4319–4324.
   PubMed Web of Science ®Google Scholar
• Haxhinasto S, Mathis D, Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J Exp Med. 2008; 205 3: 565–574.
   PubMed Web of Science ®Google Scholar
• Sauer S, Bruno L, Hertweck A, Finlay D, Leleu M, Spivakov M, . T cell receptor signaling controls Foxp3 expression via PI3K. Akt, and mTOR. Proc Natl Acad Sci USA. 2008; 105 22: 7797–7802.
   PubMed Web of Science ®Google Scholar
• Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25 high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol. 2007; 178 4: 2579–2588.
   PubMed Web of Science ®Google Scholar
• Hahn BH, Anderson M. Le E. La Cava A. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Arth Rheum. 2008; 58 8: 2488–2497.
   Google Scholar
• Wu T, Qin X, Kurepa Z, Kumar KR, Liu K, Kanta H, . Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. J Clin Invest. 2007; 117 8: 2186–2196.
   PubMed Web of Science ®Google Scholar
• Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol. 2009; 9 5: 324–337.
   PubMed Web of Science ®Google Scholar
• Warner LM, Adams LM, Sehgal SN. Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. Arth Rheum. 1994; 37:289–297.
   PubMed Web of Science ®Google Scholar
• Fernandez D, Bonilla E, Mirza N, Perl A. Rapamycin reduces disease activity and normalizes T-cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arth Rheum. 2006; 54 9: 2983–2988.
   PubMed Web of Science ®Google Scholar
• Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S, . An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arth Rheum. 2008; 58 5: 1433–1444.
   PubMed Web of Science ®Google Scholar
• Ghosh D, Tsokos GC. Spleen tyrosine kinase (Syk): A src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory disease. Autoimmunity. 2009a.
   Web of Science ®Google Scholar
• Gergely PJ, Grossman C, Niland B, Puskas F, Neupane H, Allam F, . Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arth Rheum. 2002; 46:175—90.
   PubMedGoogle Scholar
• Nagy G, Barcza M, Gonchoroff N, Phillips PE, Perl A. Nitric oxide-dependent mitochondrial biogenesis generates Ca2+ signaling profile of lupus T cells. J Immunol. 2004; 173 6: 3676–3683.
   PubMed Web of Science ®Google Scholar
• Oates JC. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity. 2009a16.
   Web of Science ®Google Scholar
• Perl A, Gergely PJr, Nagy G, Koncz A, Banki K. Mitochondrial hyperpolarization: A checkpoint of T cell life, death, and autoimmunity. Trends Immunol. 2004; 25:360–367.
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Suto R, Anderson KM, Srivastava PK. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-{kappa}B pathway. Int Immunol. 2000; 12 11: 1539–1546.
   PubMed Web of Science ®Google Scholar
• Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, . Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med. 2008; 205 13: 3007–3018.
   PubMed Web of Science ®Google Scholar
• Jego G, Palucka AK, Blanck JP, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 19192: 225–234.
   Google Scholar
• Banchereau J, Pascual V, Type I. interferon in systemic lupus erythematosus an other autoimmune diseases. Immunity. 2006; 25:383–392 [Review] [100 refs].
   PubMed Web of Science ®Google Scholar
• Wickramarachchi D, Theofilopoulos AN, Kono DHImmune pathology associated with altered actin cytoskeleton regulation.. 2009; 43 1: 64–75.
   Google Scholar
• Haraldsson MK, Louis-Dit-Sully CA, Lawson BR, Sternik G, Santiago-Raber ML, Gascoigne NRJ, . The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. Immunity. 2008; 28 1: 40–51.
   PubMed Web of Science ®Google Scholar
• Avalos AM, Kiefer K, Tian J, Christensen S, Shlomchik MJ, Coyle AJ, . RAGE-independent autoreactive B cell activation in response to chromatin and HMGB1/DNA immune complexes. Autommunity. 2009a.
   Web of Science ®Google Scholar
• Avalos AM, Busconi L, Marshak-Rothstein A. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity. 2009a.
   Web of Science ®Google Scholar
• Jacob N, Stohl WAutoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: Past, present, and future. Autoimmunity. 2009.
   Google Scholar
• Sherer Y, Zinger H, Shoenfeld Y. Atherosclerosis in systemic lupus erythematosus. Autoimmunity. 2009.
   Google Scholar
• George J, Afek A, Gilburd B, Levkovitz H, Shaish A, Goldberg I, . Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis. Atherosclerosis. 1998; 138 1: 147–152.
   PubMed Web of Science ®Google Scholar
• Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, . Linga Reddy MVP Sanchez E. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet. 2008; 40 2: 211–216.
   Google Scholar
• Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, . Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX [see comment]. New Engl J Med. 2008; 358 9: 900–909.
   PubMed Web of Science ®Google Scholar